Three-quarters of China's online shoppers make purchases at least weekly, most with their smartphones
Instead of everybody, the tax preparer wants higher-income folk
The latest CBO forecasts are that the law will cover more people and cost a lot less than expected
A design flaw in Android 4.1.1 makes millions of smartphones still vulnerable to hackers
That's what a Goldman Sachs fund and a bevy of hedge funds say it should do
Even Thomas Edison and Leonardo da Vinci benefited from collaboration
An app called CUPS enables a subscription service to almost 40 independent New York City coffee shops
The 85 Broads business leader and former Citigroup and Bank of America executive says women must master confidence and negotiating before their careers get off the ground
Nearly half of small business owners don't work with an accountant. Almost as many spend 80 hours on taxes
Founders: Dr. Mark Chandler and Craig Benson (The company was formed in 1998 as a wholly owned subsidiary of Luminex Corp. (LMNX) and subsequently spun off in 2002 as a private management-owned entity.)
VC Investment over the last four quarters: $25 million
With 95 employees worldwide, Rules-Based Medicine, a biomarker testing company, is actively developing diagnostic tests to detect the presence of complex diseases and conditions in the areas of neuropsychiatry, nephrology, immunology, and cardiology. The company is also developing what it calls the first fully closed reproducible whole-blood culture system. Despite the recession, Rules-Based Medicine's founders remain optimistic about its prospects and those of its peers that promote efficiency and cost savings for drug development and diagnostics customers.
Key to startup success: "We took a customer-focused approach to biotechnology, which drove our decision to commit resources to developing much needed comprehensive biomarker content. ... Our customers have essentially directed and funded our R&D since inception."